The Japanese big pharma adds the new gene therapy candidate to its pipeline in a US$50 million deal in equity and upfront ...

Evaxion’s proprietary AI-Immunology platform has shown in clinical trials that it can select clinically relevant cancer ...

As cell therapies continue to advance, the need for better automated, large-scale manufacturing options increases.

This year’s Nobel prize in physiology or medicine has been awarded to Victor Ambros and Gary Ruvkun for their groundbreaking ...

The UK cell therapy biotech will now advance its first candidate cell therapy to clinical trials for treatment of liver ...

Rebekah's father passed on his passion for science and problem solving to her and much her of childhood was spent doing fun ...

David Carbone, Director of the James Thoracic Oncology Center and Professor of Internal Medicine at The Ohio State University ...

Bristol Myers Squibb (BMS) acquired Karuna Therapeutics, the developer of KarXT, in a deal worth US $14.0 billion in equity ...

The newly opened Biotech Center of Excellence will be dedicated to developing and producing biological drugs, housing the ...

At this October’s CPHI event being held in Milan, dsm-firmenich, is inviting stakeholders across the pharmaceutical market to ...

The current status of the Biosecure Act is that it was passed ​ by the US House of Representatives on Sep 9, with a vote of 306-81 for the bill across both parties. It is now awaiting a vote by the US ...

The company will introduce its innovative siliconized moulded glass vials, positioning itself as the only global supplier ...